- Home
- ADIL vs QNME Comparison
ADIL vs QNME Comparison
Compare ADIL & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.18
N/A
Current Price
$0.41
Company Overview
Basic Information| Metric | ADIL | QNME |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated Freight & Logistics |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 11.4M |
| IPO Year | 2017 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ADIL | QNME |
|---|---|---|
| Price | $4.18 | $0.41 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | 31.6K | ★ 4.0M |
| Earning Date | 11-12-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.83 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,850,681.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 111.79 |
| 52 Week Low | $0.13 | $0.26 |
| 52 Week High | $9.53 | $1.40 |
Technical Indicators
Market Signals| Indicator | ADIL | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 48.37 | 41.01 |
| Support Level | $3.80 | $0.29 |
| Resistance Level | $4.94 | $0.41 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 65.00 | 1.08 |
Price Performance
Historical Comparison ADIL
QNME
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.